Skip to main content
Go to homepage

Grand Rounds: A Pilot Program Using Hydroxyurea to Treat Children with Sickle Cell Disease in Haiti

04-21-2017

By Nick McGregor, MD , Fellows, Haslinger Family Pediatric Palliative Care Center, Akron Children's Hospital, Akron, OH


Objectives (Educational Content) :

1. Recognize the burden of sickle cell disease in Haiti. 2. Explain why hydroxyurea may be an ideal intervention for SCD in Haiti. 3. Describe the outcomes of our project using HU to treat children with sickle cell disease in Haiti.

Target Audience:

General pediatricians, family physicians, nurse practitioners, physician assistants, social workers, psychologists and nurses.

Identified Gap:

With the success of the use of hydroxyurea in adults, its potential for successful treatment of sickle cell disease in children will reduce the severity of the disease as well as lessen some of the symptoms, improving pediatric patient outcome.

Estimated Time to Complete the Educational Activity:

1 hour

Expiration Date for CME Credit:

04-20-2018

Method of Physician Participation in the Learning Process:

The learner will view the presentation, successfully complete a post-test and complete an activity evaluation.

Evaluation Methods:

All learners must successfully complete a post-test, as well as an activity evaluation, to claim CME credit.

Accreditation Statement:

Children’s Hospital Medical Center of Akron is accredited by the Ohio State Medical Association to provide continuing medical education for physicians. CHMCA designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit ™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.